Evidence map›Paper›PMID 40991016›Full record

ReviewAbdominal radiology (New York)2026

Radiomics-based artificial intelligence (AI) models in colorectal cancer (CRC) diagnosis, metastasis detection, prognosis, and treatment response prediction.

Reza Elahi, Parsa Karami, Mohammadreza Amjadzadeh, Mahdis Nazari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reza ElahiDepartment of Radiology, Zanjan University of Medical Sciences, Zanjan, Iran, Islamic Republic of. rezaelahi96research@gmail.com.
Parsa KaramiDepartment of Radiology, Zanjan University of Medical Sciences, Zanjan, Iran, Islamic Republic of.
Mohammadreza AmjadzadehDepartment of Radiology, University of Pittsburgh, Pittsburgh, PA, USA.
Mahdis NazariDepartment of Radiology, Zanjan University of Medical Sciences, Zanjan, Iran, Islamic Republic of.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most common cause of cancer-related morbidity and mortality in the world. Radiomics and radiogenomics are utilized for the high-throughput quantification of features from medical images, providing non-invasive means to characterize cancer heterogeneity and gain insight into the underlying biology. Such radiomics-based artificial intelligence (AI)-methods have demonstrated great potential to improve the accuracy of CRC diagnosis and staging, to distinguish between benign and malignant lesions, to aid in the detection of lymph node and hepatic metastasis, and to predict the effects of therapy and prognosis for patients. This review presents the latest evidence on the clinical applications of radiomics models based on different imaging modalities in CRC. We also discuss the challenges facing clinical translation, including differences in image acquisition, issues related to reproducibility, a lack of standardization, and limited external validation. Given the progress of machine learning (ML) and deep learning (DL) algorithms, radiomics is expected to have an important effect on the personalized treatment of CRC and contribute to a more accurate and individualized clinical decision-making in the future.

Indexed as

Artificial IntelligenceColorectal NeoplasmsImage Interpretation, Computer-AssistedHumansNeoplasm MetastasisPrognosisRadiomicsColorectal cancer (CRC)DiagnosisPrognosisRadiologyRadiomicsStagingTreatment response

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.